Clinical Trials Research Group - Recent Publications

Clifford JJ, Drago J, Natoli AL, Wong JY, Kinsella A, Waddington JL, Vaddadi KS.(2002). Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease. Neuroscience. 109(1):81-8.

Damodaran, S. (2005). Seclusion in acute adult impatient units. Paper presented to Chief Psychiatrists Forum, Melbourne July 2005.

Damodaran, S., & Cockram, A. (2005). Clinical governance in mental health. Australian and New Zealand Journal of Psychiatry 39, A97.

Damodaran, S., & Lee, P. (2005). Patient safety in mental health. Australian and New Zealand Journal of Psychiatry 39, A97.

Das UN, Vaddadi KS.Essential fatty acids in Huntington's disease. Nutrition. 2004 Oct;20(10):942-7.

Ilett KF, Hackett LP, Kristensen JH, Vaddadi KS, Gardiner SJ, Begg EJ.(2004) Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann Pharmacother. 38(2):273-6.

Puri BK, Bydder GM, Counsell SJ, Corridan BJ, Richardson AJ, Hajnal JV,Appel C, Mckee HM,
Vaddadi KS, Horrobin DF.(2002) MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment.Neuroreport. 13(1):123-6.

Puri BK, Leavitt BR, Hayden MR, Ross CA, Rosenblatt A, Greenamyre JT, Hersch S, Vaddadi KS, Sword A, Horrobin DF, Manku M, Murck H. (2005) Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial. Neurology. 65(2):286-92.

Rao, S et al. (1991) Clomipramine induced mania. Indian Journal of Psychiatry. 33 (3) 252-253

Rao, S et al. (1991) Co-existing bipolar affective disorder and obsessive compulsive disorder. Abstract published in Biological Psychiatry. 29: 333s-701s

Vaddadi K.(2002) Effective clinical innovation.Lancet.360(9346):1697; author reply 1697-8. No abstract available.

Vaddadi KS, Soosai E, Chiu E, Dingjan P.A (2002) randomised, placebo-controlled, double blind study of treatment of Huntington's disease with unsaturated fatty acids. Neuroreport. 2002 Jan 21;13(1):29-33. Erratum in: Neuroreport. 13(2):inside back cover.

Vaddadi KS, Soosai E, Vaddadi G. (2003) Low blood selenium concentrations in schizophrenic patients on clozapine. Br J Clin Pharmacol. 55(3):307-9.

Wong, M., & Tye, C. (2005). Low hospital inpatient readmission rate in patients with borderline personality disorder: a naturalistic study at Southern Health, Victoria. Australian and New Zealand Journal of Psychiatry 39, 607-610.